Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Predictive Oncology Partners with Cancer Research Horizons
Saturday, March 18, 2023Predictive Oncology together with Cancer Research Horizons announce that they have partnered to drive the development of oncology drugs utilising Predictive Oncologys PEDAL platform This collaboration with Cancer Research Horizons represents a fundam...
Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group
Saturday, March 18, 2023Processa Pharmaceuticals announced that the Company has dosed the first patient in its NGCCapecitabine combination of PCS and capecitabine mg dose group The Processa NGCs already have clinical evidence to support safety and efficacy while targeting...
Novartis Tafinlar + Mekinist Approved by FDA for Paediatric Patients
Friday, March 17, 2023Novartis announced the US Food and Drug Administration FDA granted approval for Tafinlar dabrafenib Mekinist trametinib for the treatment of paediatric patients year of age and older with lowgrade glioma LGG with a BRAF VE mutation who require syst...
Evotec Partners with Bristol Myers Squibb
Friday, March 17, 2023Evotec announced progress within the Companys strategic partnership with Bristol Myers Squibb relating to building a molecular gluebased pipeline Evotec and Bristol Myers Squibb entered into strategic protein degradation partnership in and expanded...
Ipsen Announces New FDA PDUFA Date for Investigational Palovarotene
Friday, March 17, 2023Ipsen announced that the US Food and Drug Administration FDA Prescription Drug User Fee Act PDUFA goal date for the resubmitted New Drug Application NDA for investigational palovarotene as a potential treatment for fibrodysplasia ossificans progressi...
Telix Pharmaceuticals Announces US FDA Expanded Indication for Illuccix®
Friday, March 17, 2023Telix Pharmaceuticals announces that the United States Food and Drug Administration FDA has approved a supplementary New Drug Application sNDA for Illuccix kit for the preparation of gallium Ga gozetotide injection to enable its use for the selectio...
Aitia and UCB Announce Strategic Drug Discovery Collaboration
Thursday, March 16, 2023UCB and Aitia announced an early drug discovery collaboration focused on the discovery and validation of novel drug targets and drug candidates for Huntingdons disease The collaboration seeks to validate novel drug targets that are causally linked to...
Prelude Therapeutics Announces Clinical Trial Collaboration with BeiGene
Thursday, March 16, 2023Prelude Therapeutics Incorporated announced a clinical trial collaboration with BeiGene for future evaluation of its investigational CDK inhibitor PRT in combination with BeiGenes BTK inhibitor zanubrutinib in haematologic malignancies Under terms of...
Relief Therapeutics Provides Update from ACER Therapeutics on OLPRUVA™
Thursday, March 16, 2023Relief Therapeutics announces that its collaboration partner ACER Therapeuticshas provided an update on commercial launch activities for OLPRUVA Relief Therapeutics entered a collaboration and licence agreement with Acre Therapeutics Inc in March fo...
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003
Thursday, March 16, 2023Alphamab Oncology announced that the first patient has been dosed with mgkg in a Phase I clinical study JSKN of JSKN an AntiHER bispecific ADC JSKN was approved by the Bellberry Human Research Ethics Committee in Australia JSKN and the first patient
